Continuing Medical Education Programs
All programs are available free to the public.
Continuing Medical Education Programs
All programs are available free to the public.
Bispecific Therapy: Advancing Patient Care through Targeted Treatment
Date: March 11, 2025 @ 5:00pm ET
Format: Live, virtual webinar
Myeloma Rounds San Francisco
Date: March 22, 2025 @ 9:30 AM PT
Location: San Francisco, CA
In-Person Rounds Coming Soon:
Myeloproliferative Neoplasms (MPNs) Rounds Chicago
April 23, 2025, Evening
Dinner and Networking, followed by Education Program
Free 2.0 CME/CE credits/contact hours will be provided to physicians, physician associates, pharmacists, and nurses.
Other Resources
Participate and earn CME credit:
Key Updates and Expert Discussion from Myeloma Rounds
This activity is intended for hematologists-oncologists, medical oncologists, physician associates, nurse practitioners, nurses and pharmacists involved in the care of patients with myeloma.
Treating Myelodysplastic Syndromes Transformation to Acute Myeloid Leukemia
This activity is intended for hematologist/oncologists, oncology nurses, and other healthcare professionals involved in the care of patients with hematologic malignancies.
Evolving Treatment Strategies in Pediatric Leukemia
This activity is intended for pediatric hematologist/oncologists, oncology nurses, social workers, and other healthcare professionals involved in the care of pediatric patients with hematologic malignancies.
Treating Myeloproliferative Neoplasms: Spotlight on Myelofibrosis
This activity is intended for hematologist/oncologists, oncology nurses, physician assistants, social workers, and other healthcare professionals involved in the care of patients with myeloproliferative neoplasms (MPNs).
Clinician Strategies and Resources: Caring for AYAs as they Transition to Cancer Survivorship
This accredited activity is intended for hematologist/oncologists, APPs, nurses, social workers, and other healthcare professionals involved in the care of adolescent and young adult (AYA) patients with cancer and cancer survivors.
Clinical Advances in BTK Inhibitors for Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma: Where disease-, treatment-, and patient-centric education unite.
This CME education series is intended for hematology/oncology specialists and other members of the oncology multidisciplinary team.
Highlights of Myeloma Rounds
This activity is intended for hematologists-oncologists, medical oncologists, nurse practitioners, nurses and pharmacists involved in the care of patients with myeloma.
Genomics Essentials in Hematologic Malignancies (GENOM)
In this new activity, learn more about the role of genomics in treating hematologic malignancies and build your confidence through this interactive education activity!
The Importance of Clinical Trials to Treat Blood Cancer
This activity is intended for oncologists and hematologists, advanced practice providers, and nurses involved in the care of patients in community and academic practices.
Treating Adolescents and Young Adults (AYA) with Blood Cancer
This activity is intended for hematologist/oncologists, nurses, social workers, and other healthcare professionals involved in the care of patients with blood cancer.
Treating Indolent Lymphoma: Common and Rare Types
This activity is intended for hematologist/oncologists, oncology nurses, and other healthcare professionals involved in the care of patients with lymphoma.
Clinical Advances in BTK Inhibitors for Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma
This CME Education Series is intended for hematology/oncology specialists, pathologists, and oncology care teams.